What WhiteOak Capital Pharma and Healthcare Fund bought and sold in September 2026
This compares the fund's portfolio at the end of September 2026 with the month before. Both come from the monthly portfolio statement of WhiteOak Capital Mutual Fund.
WhiteOak Capital Pharma and Healthcare Fund Stocks Bought and Sold
All changes are between August 2026 and September 2026
More
| Divi's Laboratories Limited | Added | +3.6% | 8.36% |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Added | +7.8% | 7.11% |
| Apollo Hospitals Enterprise Limited | Reduced | −11.2% | 3.75% |
| Laurus Labs Limited | Added | +2.6% | 3.91% |
| Cipla Limited | Added | +21.5% | 3.68% |
| Sai Life Sciences Limited | Reduced | −3.0% | 3.28% |
| Max Healthcare Institute Limited | Reduced | −30.4% | 1.84% |
| IPCA Laboratories Limited | Added | +13.9% | 2.88% |
| Zydus Lifesciences Limited | Added | +11.9% | 2.81% |
| Thyrocare Technologies Limited | Added | +14.5% | 2.27% |
| Ajanta Pharma Limited | Added | +19.6% | 2.01% |
| Global Health Limited | Added | +5.4% | 1.82% |
| Vijaya Diagnostic Centre Limited | Added | +6.5% | 1.56% |
| Onesource Specialty Pharma Limited | Added | +57.3% | 1.55% |
| Mankind Pharma Limited | New | New | 1.20% |
| Manipal Health Enterprises Ltd | Reduced | −50.0% | 0.52% |
| Pfizer Limited | Sold out | −100% | was 1.14% |
| Piramal Pharma Limited | New | New | 1.06% |
| Aether Industries Limited | Added | +10.9% | 1.05% |
| Gland Pharma Limited | Added | +11.5% | 0.93% |
| Poly Medicure Limited | Sold out | −100% | was 0.76% |
| Novartis India Limited | New | New | 0.24% |
| Cohance Lifesciences Limited | Sold out | −100% | was 0.21% |
| Bharat Parenterals Limited | Added | +99.4% | 0.10% |
No stocks in this group for September 2026.
A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.
Frequently Asked Questions
Which new stocks did WhiteOak Capital Pharma and Healthcare Fund buy in September 2026?
It bought 3 new stocks: Mankind Pharma Limited (1.20%), Piramal Pharma Limited (1.06%) and Novartis India Limited (0.24%). Each figure is the stock's share of the fund at the end of September 2026.
Which stocks did WhiteOak Capital Pharma and Healthcare Fund sell completely in September 2026?
It sold all its shares in Pfizer Limited (1.14%), Poly Medicure Limited (0.76%) and Cohance Lifesciences Limited (0.21%). Each figure is the stock's share of the fund at the end of August 2026.
Which stocks did WhiteOak Capital Pharma and Healthcare Fund buy more of in September 2026?
The largest increases in shares held were Bharat Parenterals Limited (+99.4%), Onesource Specialty Pharma Limited (+57.3%), Cipla Limited (+21.5%), Ajanta Pharma Limited (+19.6%) and Thyrocare Technologies Limited (+14.5%). It added to 9 more.
Which stocks did WhiteOak Capital Pharma and Healthcare Fund sell part of in September 2026?
The largest cuts in shares held were Manipal Health Enterprises Ltd (−50.0%), Max Healthcare Institute Limited (−30.4%), Apollo Hospitals Enterprise Limited (−11.2%) and Sai Life Sciences Limited (−3.0%).
How are these changes worked out?
WealthGamma compares the number of shares WhiteOak Capital Pharma and Healthcare Fund held on 30-09-2026 with 31-08-2026. Both figures come from the monthly portfolio statement of WhiteOak Capital Mutual Fund. A change in share price alone does not count as buying or selling.
See NAV, expense ratio and full holdings of WhiteOak Capital Pharma and Healthcare Fund
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.